Abstract | UNLABELLED:
Myocardial infarction leads to a reduction in nitric oxide (NO) bioavailability and an increase in reactive oxygen species (ROS) levels. This scenario has been shown to be detrimental to the heart. Recent studies have shown that thyroid hormone (TH) administration presents positive effects after ischaemic injury. Based on this, the aim of this study was to evaluate the effect of TH on NO bioavailability as well as on endothelial nitric oxide synthase (eNOS) expression after myocardial infarction. Male Wistar rats were divided into three groups: Sham-operated ( SHAM), infarcted (AMI) and infarcted + TH (AMIT). During 26 days, the AMIT group received T3 and T4 (2 and 8 µg/100 g/day, respectively) by gavage, while SHAM and AMI rats received saline. After this, the rats underwent echocardiographic analysis were sacrificed, and the left ventricle was collected for biochemical and molecular analysis. STATISTICAL ANALYSIS: one-way ANOVA with Student-Newman-Keuls post test. AMI rats presented a 38% increase in ROS levels. TH administration prevented these alterations in AMIT rats. The AMIT group presented an increase in eNOS expression, in NOS activity and in nitrite levels. TH administration also increased PGC-1α expression in the AMIT group. In conclusion, TH effects seem to involve a modulation of eNOS expression and an improvement in NO bioavailability in the infarcted heart.
|
Authors | Alexandre Luz de Castro, Angela Vicente Tavares, Rafael Oliveira Fernandes, Cristina Campos, Adriana Conzatti, Rafaela Siqueira, Tânia Regina G Fernandes, Paulo Cavalheiro Schenkel, Carmem L Sartório, Susana Llesuy, Adriane Belló-Klein, Alex Sander da Rosa Araujo |
Journal | Molecular and cellular biochemistry
(Mol Cell Biochem)
Vol. 408
Issue 1-2
Pg. 235-43
(Oct 2015)
ISSN: 1573-4919 [Electronic] Netherlands |
PMID | 26160278
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Reactive Oxygen Species
- Triiodothyronine
- Nitric Oxide
- Nitric Oxide Synthase Type III
- Nos3 protein, rat
- Thyroxine
|
Topics |
- Animals
- Disease Models, Animal
- Heart Ventricles
(drug effects, metabolism)
- Male
- Myocardial Infarction
(drug therapy, metabolism, pathology)
- Nitric Oxide
(metabolism)
- Nitric Oxide Synthase Type III
(metabolism)
- Rats
- Rats, Wistar
- Reactive Oxygen Species
(metabolism)
- Thyroxine
(administration & dosage, pharmacology)
- Triiodothyronine
(administration & dosage, pharmacology)
|